| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6350468 | LABS JUVISE | Double capsule for the administration of active principles in multiple therapies |
Dec, 2018
(5 years ago) | |
Pylera is owned by Labs Juvise.
Pylera contains Bismuth Subcitrate Potassium; Metronidazole; Tetracycline Hydrochloride.
Pylera has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Pylera are:
- US6350468
Pylera was authorised for market use on 28 September, 2006.
Pylera is available in capsule;oral dosage forms.
Pylera can be used as treatment of patients with h. pylori infection and duodenal ulcer disease.
The generics of Pylera are possible to be released after 14 December, 2018.
Market Authorisation Date: 28 September, 2006
Treatment: Treatment of patients with h. pylori infection and duodenal ulcer disease
Dosage: CAPSULE;ORAL
How can I launch a generic of PYLERA before it's drug patent expiration?
More Information on Dosage
PYLERA family patents
